{"database": "lobbying", "table": "lobbying_activities", "rows": [[1071579, "1f577934-986d-4181-8f9f-9bec69e207df", "Q1", "HOLLAND & KNIGHT LLP", 18466, "ALLIANCE FOR REGENERATIVE MEDICINE", 2011, "first_quarter", "SCI", "Advocate for funding for regenerative medicine companies; Advocate for NIH funding for regenerative medicine research.  Advocate for new regulations re:  approval of regenerative medicine products.  Advocate for funding for the FDA.  Work with NIST on standards for reginerative medicine products. Advocate for assessment of federal regenerative medicine activities.  Draft legislation to support regenerative medicine research and development.", "Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institute of Standards & Technology (NIST),Natl Institutes of Health (NIH),SENATE", 80000, null, 0, 0, "2011-04-06T12:52:20.593000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1071579"], "units": {}, "query_ms": 0.5109999910928309, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}